We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$154M
AUM Growth
+$16.2M
Cap. Flow
+$12.3M
Cap. Flow %
7.94%
Top 10 Hldgs %
34.62%
Holding
83
New
3
Increased
25
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
TNL icon
Travel + Leisure Co
TNL
+$3.31M
2
CPRI icon
Capri Holdings
CPRI
+$3.24M
3
DB icon
Deutsche Bank
DB
+$2.36M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.13M
5
QCOM icon
Qualcomm
QCOM
+$957K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$497K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$133K
3
MS icon
Morgan Stanley
MS
+$128K
4
MDT icon
Medtronic
MDT
+$126K
5
SLB icon
SLB Ltd
SLB
+$110K

Sector Composition

Rank Sector Weight
1 Healthcare 19.69%
2 Technology 18.92%
3 Financials 15.76%
4 Industrials 8.77%
5 Communication Services 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYN icon
26
Rayonier
RYN
$6.49B
$3.23M 2.09%
123,771
+5,467
+5% +$141K
BP icon
27
BP
BP
$113B
$3.21M 2.08%
104,431
-2,428
-2% -$75.5K
EFA icon
28
iShares MSCI EAFE ETF
EFA
$76.4B
$2.99M 1.94%
45,860
+17,390
+61% +$1.13M
LYB icon
29
LyondellBasell Industries
LYB
$19.5B
$2.7M 1.75%
32,020
+3,200
+11% +$266K
IBM icon
30
IBM
IBM
$202B
$2.69M 1.75%
18,322
-3,297
-15% -$497K
EMR icon
31
Emerson Electric
EMR
$82.9B
$2.51M 1.63%
42,125
+560
+1% +$33.2K
CI icon
32
Cigna
CI
$76.6B
$2.5M 1.62%
14,960
+125
+0.8% +$20.1K
DB icon
33
Deutsche Bank
DB
$66.3B
$2.37M 1.54%
+133,310
New +$2.36M
BCE icon
34
BCE
BCE
$19.9B
$2.26M 1.46%
50,117
+6,601
+15% +$298K
AGN.PRA
35
DELISTED
Allergan plc
AGN.PRA
$1.63M 1.05%
1,882
+120
+7% +$101K
MDT icon
36
Medtronic
MDT
$107B
$1.53M 0.99%
17,233
-1,490
-8% -$126K
SRCLP
37
DELISTED
Stericycle, Inc
SRCLP
$1.44M 0.93%
22,650
+850
+4% +$60K
V icon
38
Visa
V
$677B
$1.41M 0.91%
15,050
+150
+1% +$13.9K
XOM icon
39
ExxonMobil
XOM
$651B
$1.39M 0.9%
17,247
FTV icon
40
Fortive
FTV
$19B
$1.13M 0.73%
28,380
-440
-2% -$17.3K
NVO
41
Novo Nordisk
NVO
$216B
$1.04M 0.68%
48,598
EEM icon
42
iShares MSCI Emerging Markets ETF
EEM
$28B
$988K 0.64%
23,862
+3,050
+15% +$124K
SHW icon
43
Sherwin-Williams
SHW
$78.3B
$875K 0.57%
7,482
VFC icon
44
VF Corp
VFC
$6.68B
$850K 0.55%
15,677
MSFT icon
45
Microsoft
MSFT
$2.84T
$802K 0.52%
11,634
ORCL icon
46
Oracle
ORCL
$331B
$626K 0.41%
12,490
BIVV
47
DELISTED
Bioverativ Inc. Common Stock
BIVV
$491K 0.32%
8,155
-57
-0.7% -$3.25K
ETN icon
48
Eaton
ETN
$157B
$474K 0.31%
6,095
+250
+4% +$19.1K
ABBV icon
49
AbbVie
ABBV
$458B
$389K 0.25%
5,370
JNJ icon
50
Johnson & Johnson
JNJ
$635B
$387K 0.25%
2,923
+100
+4% +$12.8K

Similar funds

Lipe & Dalton's Q2 2017 Portfolio in Review

As of Q2 2017, Lipe & Dalton held 83 positions worth $154M, up 12% from $138M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Lipe & Dalton deployed $12.3M of net new capital in Q2 2017, opening 3 new positions and adding to 25 existing holdings. Its largest new stake was Travel + Leisure Co: 76,384 shares worth $3.46M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IBM, an estimated $497K trimmed.

  • Lipe & Dalton's largest Q2 2017 buy was Travel + Leisure Co: 76,384 shares worth $3.46M.
  • Lipe & Dalton added most to iShares MSCI EAFE ETF in Q2 2017, an estimated $1.13M increase.
  • Lipe & Dalton's biggest Q2 2017 reduction was IBM, cutting an estimated $497K.
  • Lipe & Dalton fully exited Berkshire Hathaway Class B in Q2 2017, selling an estimated $133K.
  • Lipe & Dalton's ten largest holdings make up 35% of its $154M portfolio in Q2 2017.
  • Lipe & Dalton opened 3 new positions and closed 1 in Q2 2017.
  • Lipe & Dalton's portfolio value rose 12% quarter-over-quarter to $154M.

Based on Lipe & Dalton's 13F filing for Q2 2017, filed 8 Aug 2017.